Hosted on MSN
Spleen-based islet transplantation restores glycemic control in type 1 diabetes without full immunosuppression
Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling long-term diabetes control without the burden of full immunosuppression.
A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink (Monday, 30 June 2025, London, United ...
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative ...
Researchers have 3D printed devices made of insulin-producing cells. These devices could enable a long-term treatment for type 1 diabetes that would let people produce their own insulin – without ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
LONDON, June 28, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results